Page 152 - 南京医科大学自然版
P. 152

第45卷第10期
               ·1520 ·                           南 京    医 科 大 学 学         报                        2025年10月


             [30]DICHTL S,LINDENTHAL L,ZEITLER L,et al. Lactate      rence[J]. FEBS J,2021,288(21):6286-6303
                   and IL6 define separable paths of inflammatory metabolic  [42]WU Y,SONG Y,WANG R,et al. Molecular mechanisms
                   adaptation[J]. Sci Adv,2021,7(26):eabg3505        of tumor resistance to radiotherapy[J]. Mol Cancer,2023,
             [31]JIN M,CAO W,CHEN B,et al. Tumor⁃derived lactate cre⁃  22(1):96
                   ates a favorable niche for tumor via supplying energy  [43]AMRUTKAR M,BERG K,BALTO A,et al. Pancreatic
                   source for tumor and modulating the tumor microenviron⁃  stellate cell⁃induced gemcitabine resistance in pancreatic
                   ment[J]. Front Cell Dev Biol,2022,10:808859       cancer is associated with LDHA⁃ and MCT4⁃mediated en⁃
             [32]ABAZA M,LUQMANI Y A. The influence of pH and hy⁃    hanced glycolysis[J]. Cancer Cell Int,2023,23(1):9
                   poxia on tumor metastasis[J]. Expert Rev Anticancer  [44]YANG X,LU Y,HANG J,et al. Lactate⁃modulated immu⁃
                   Ther,2013,13(10):1229-1242                        nosuppression of myeloid ⁃ derived suppressor cells con⁃
             [33]COLEGIO O R,CHU N,SZABO A L,et al. Functional po⁃   tributes to the radioresistance of pancreatic cancer[J].
                   larization of tumour⁃associated macrophages by tumour⁃  Cancer Immunol Res,2020,8(11):1440-1451
                   derived lactic acid[J]. Nature,2014,513(7519):559-563  [45]GAN J,WANG W,YANG Z,et al. Prognostic value of pre⁃
             [34]WANG Z,PENG W,ZHANG P,et al. Lactate in the tu⁃     treatment serum lactate dehydrogenase level in pancreatic
                   mour microenvironment:from immune modulation to ther⁃  cancer patients:a meta⁃analysis of 18 observational stud⁃
                   apy[J]. EBioMedicine,2021,73:103627               ies[J]. Medicine(Baltimore),2018,97(46):e13151
             [35]JIANG M,WANG Y,ZHAO X,et al. From metabolic by⁃  [46]YU S,XU L,QI Q,et al. Serum lactate dehydrogenase pre⁃
                   product to immune modulator:the role of lactate in tumor  dicts prognosis and correlates with systemic inflammatory
                   immune escape[J]. Front Immunol,2024,15:1492050   response in patients with advanced pancreatic cancer after
             [36]KANEMARU H,MIZUKAMI Y,KANEKO A,et al. A             gemcitabine⁃based chemotherapy[J]. Sci Rep,2017,7:
                   mechanism of cooling hot tumors:lactate attenuates in⁃  45194
                   flammation in dendritic cells[J]. iScience,2021,24(9):  [47]KERSLAKE R,PANFILOV S,MUSTAFA N,et al. Elevat⁃
                   103067                                            ed circulating lactate levels and widespread expression of
             [37]HE Z,ZHANG S. Tumor ⁃ associated macrophages and    its cognate receptor,hydroxycarboxylic acid receptor 1
                   their functional transformation in the hypoxic tumor micro⁃  (HCAR1),in ovarian cancer[J]. J Clin Med,2022,12
                   environment[J]. Front Immunol,2021,12:741305     (1):217
             [38]SAFFI G T,TO L,KLEINE N,et al. INPP4B promotes  [48]WANG X,WANG C,ZHANG H. Improvement of diagnos⁃
                   PDAC aggressiveness via PIKfyve and TRPML⁃1⁃mediat⁃  tic accuracy for pancreatic cancer with serum lactate de⁃
                   ed lysosomal exocytosis[J]. J Cell Biol,2024,223(11):  hydrogenase[J]. Cancer Manag Res,2021,13:4879-
                   e202401012                                        4886
             [39]GU X,YANG J,LAI R,et al. Impact of lactate on immune  [49]BABL N,DECKING S,VOLL F,et al. MCT4 blockade in⁃
                   cell function in the tumor microenvironment:mechanisms  creases the efficacy of immune checkpoint blockade[J]. J
                   and therapeutic perspectives[J]. Front Immunol,2025,  Immunother Cancer,2023,11(10):e007349
                   16:1563303                                   [50]HALFORD S,VEAL G J,WEDGE S R,et al. A phase Ⅰ
             [40]BOGDANOV A,BOGDANOV A,CHUBENKO V,et al.             dose⁃escalation study of AZD3965,an oral monocarboxyl⁃
                   Tumor acidity:from hallmark of cancer to target of treat⁃  ate transporter 1 inhibitor,in patients with advanced can⁃
                   ment[J]. Front Oncol,2022,12:979154               cer[J]. Clin Cancer Res,2023,29(8):1429-1439
             [41]DAMEN M P F,VAN RHEENEN J,SCHEELE C L G J.                               [收稿日期] 2025-05-19
                   Targeting dormant tumor cells to prevent cancer recur⁃                     (本文编辑:唐       震)
   147   148   149   150   151   152   153   154   155   156   157